Latest News for: nautilus

Edit

Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform (Nautilus Biotechnology Inc)

Public Technologies 18 Mar 2026
• Baylor selects the Nautilus VoyagerPlatform, now available through Early Access Program, for development of a first-in-class computational multi-omics toolkit ... About Nautilus Biotechnology, Inc ... To learn more about Nautilus, visit www.nautilus.bio.
Edit

Nautilus Energizes New Markets, Strengthens Grid, and Deepens Community Investment in 2025

Hastings Tribune 16 Mar 2026
CHICAGO, IL, March 16, 2026 (GLOBE NEWSWIRE) -- Nautilus Solar Energy (Nautilus) reached a milestone year in 2025 marked by historic growth, expanded clean energy generation, and deepened investment in the communities it serves ... .
Edit

America 250: Defense submarines and the rise of undersea warfare

Wtop 16 Mar 2026
A nuclear attack submarine may be the most formidable predator ever built. Invisible. Quiet. Lethal ...It’s currently 0200 ... In 1954, the USS Nautilus proved a submarine could remain submerged for months at a time, no longer tethered to the need for air.
Edit

Nautilus answers FAQs on seafarers’ rights amid Middle East crisis

SAFETY4SEA 06 Mar 2026
Trade unions, including Nautilus International, have explicitly reaffirmed that seafarers must not be compelled to enter Warlike or High Risk areas and must be able to refuse without fear of penalty.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Nautilus Biotechnology Inc)

Public Technologies 05 Mar 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue ... Nautilus Biotechnology, Inc ... C/O NAUTILUS BIOTECHNOLOGY, INC., 2701 EASTLAKE AVENUE EAST 3 ... C/O NAUTILUS BIOTECHNOLOGY, INC ... Nautilus Biotechnology Inc.
Edit

PharmAla Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial ...

Nasdaq Globe Newswire 03 Mar 2026
Pharmala announces a newly signed contract to supply a clinical trial, and the fulfillment of a previously announced trial ... .
Edit

Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales

Norfolk Daily News 02 Mar 2026
Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to ... .
Edit

Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales (Nautilus Biotechnology Inc)

Public Technologies 02 Mar 2026
) Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform ... To learn more about Nautilus, visit www.nautilus.bio.
Edit

Initial Registration Statement for Employee Benefit Plan (Form S-8) (Nautilus Biotechnology Inc)

Public Technologies 26 Feb 2026
NAUTILUS BIOTECHNOLOGY, INC ... This Registration Statement on Form S-8 (the "Registration Statement") is being filed to register an additional 6,323,480 shares of common stock of Nautilus Biotechnology, Inc ... 4.4 Nautilus Biotechnology, Inc.
Edit

Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K) (Nautilus Biotechnology Inc)

Public Technologies 26 Feb 2026
As a result of the Business Combination, ARYA changed its name to "Nautilus Biotechnology, Inc." and Mako Merger Sub merged with and into Legacy Nautilus with Legacy Nautilus surviving as ...
×